570 related articles for article (PubMed ID: 30522491)
1. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
[TBL] [Abstract][Full Text] [Related]
2. Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin.
Sicras-Mainar A; Rejas-Gutiérrez J; Pérez-Paramo M; Sánchez-Alvarez L; Navarro-Artieda R; Darbà J
Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):45-57. PubMed ID: 30182806
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and economic consequences in patients initiating therapy with clopidogrel brand-name vs. generic: A real-life retrospective study].
Sicras-Mainar A; Escobar-Cervantes C; Micó-Pérez RM; Llisterri-Caro JL
Semergen; 2020; 46(1):16-26. PubMed ID: 31345684
[TBL] [Abstract][Full Text] [Related]
4. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
Tran YB; Frial T; Miller PS
Can J Clin Pharmacol; 2007; 14(2):e205-14. PubMed ID: 17556788
[TBL] [Abstract][Full Text] [Related]
5. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
[TBL] [Abstract][Full Text] [Related]
7. Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.
Corrao G; Soranna D; Arfè A; Casula M; Tragni E; Merlino L; Mancia G; Catapano AL
Eur J Intern Med; 2014 Oct; 25(8):745-50. PubMed ID: 25200803
[TBL] [Abstract][Full Text] [Related]
8. The impact of manufacturer coupon use in the statin market.
Daugherty JB; Maciejewski ML; Farley JF
J Manag Care Pharm; 2013; 19(9):765-72. PubMed ID: 24156645
[TBL] [Abstract][Full Text] [Related]
9. Comparison of adherence, persistence, and clinical outcome of generic and brand-name statin users: A retrospective cohort study using the Japanese claims database.
Gao J; Seki T; Kawakami K
J Cardiol; 2021 May; 77(5):545-551. PubMed ID: 33371973
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic consequences of treating patients with peripheral neuropathic pain with brand name or generic drugs in routine clinical practice: The effects of age and sex.
Navarro-Artieda R; Rejas-Gutiérrez J; Pérez-Paramo M; Sicras-Mainar A
Neurologia (Engl Ed); 2018 Apr; 33(3):141-153. PubMed ID: 27321171
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of compliance and cost effectiveness between brand-name statins and generic statins].
He L; Du X; Wang WH; Ma CS
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov; 41(11):1900-1904. PubMed ID: 33297658
[No Abstract] [Full Text] [Related]
13. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
[TBL] [Abstract][Full Text] [Related]
14. Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database.
Sumarsono A; Lalani HS; Vaduganathan M; Navar AM; Fonarow GC; Das SR; Pandey A
JAMA Cardiol; 2021 Jan; 6(1):92-96. PubMed ID: 32902560
[TBL] [Abstract][Full Text] [Related]
15. [Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].
Degli Esposti L; Sangiorgi D; Arca M; Vigna GB; Budal S; Degli Esposti E
Monaldi Arch Chest Dis; 2011 Dec; 76(4):160-7. PubMed ID: 22567731
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments.
Cicero AF; Derosa G; Parini A; Baronio C; Borghi C
Atherosclerosis; 2014 Jul; 235(1):81-3. PubMed ID: 24819746
[TBL] [Abstract][Full Text] [Related]
17. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
[TBL] [Abstract][Full Text] [Related]
18. The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices.
Plans-Rubió P
Am J Cardiovasc Drugs; 2010; 10(6):369-82. PubMed ID: 21090830
[TBL] [Abstract][Full Text] [Related]
19. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
